Advanced Or Metastatic Malignant Solid Tumors clinical trials

Explore recruiting advanced or metastatic malignant solid tumors clinical trials.

Recruiting advanced or metastatic malignant solid tumors studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Or Metastatic Malignant Solid Tumors trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A first-in-human, open-label, dose escalation trial with expansion cohorts to evaluate the safety and preliminary efficacy of BNT314 as monotherapy in patients with advanced malignant solid tumors

Denmark, Spain, Belgium

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Advanced Or Metastatic Malignant Solid Tumors trials by city

Advanced Or Metastatic Malignant Solid Tumors clinical trials

Recruiting advanced or metastatic malignant solid tumors studies right now

Combination of CAR-DC Vaccine and ICIs in Malignant Tumors

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC

A Study of MT027 in Patients with Pleural Malignant Tumors

AMT-253 in Patients With Advanced Solid Tumours

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors

Study of IBI3005 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors

A Dose Escalation and Dose Expansion Trial of WTX212A in the Treatment of Patients with Advanced Malignant Tumors

TR-002 for the Treatment of Advanced Unresectable Metastatic Solid Tumors Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid Tumors

Also recruiting in Europe

A first-in-human, open-label, dose escalation trial with expansion cohorts to evaluate the safety and preliminary efficacy of BNT314 as monotherapy in patients with advanced malignant solid tumors

Advanced Or Metastatic Malignant Solid Tumors trials by city

Other conditions